Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: Insulin dependency of the VLDL receptor

Endocrinology

Volumn 146, Issue 8, 2005, Pages 3286-3294

  Iwasaki, Tadao ^a   Takahashi, Sadao ^b   Takahashi, Masao ^c   Zenimaru, Yasuo ^b   Kujiraoka, Takeshi ^a   Ishihara, Mitsuaki ^a   Nagano, Makoto ^a   Suzuki, Jinya ^b   Miyamori, Isamu ^b   Naiki, Hironobu ^b   Sakai, Juro ^d,e   Fujino, Takahiro ^f   Miller, Norman E ^g   Yamamoto, Tokuo T ^h   Hattori, Hiroaki ^a  

^a BML   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c Hiratsuka Kyosai Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f EHIME UNIVERSITY   (Japan)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; INSULIN; LIPOPROTEIN LIPASE; MESSENGER RNA; SOMATOMEDIN C; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENETIC TRANSCRIPTION; HEART; HYPERLIPIDEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENCE; LIVER; MALE; MEASUREMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

ADIPOSE TISSUE; ANIMALS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, EXPERIMENTAL; HEART; HYPERLIPIDEMIAS; INSULIN; LIPOPROTEINS; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRIGLYCERIDES;

EID: 23044457331     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0043     Document Type: Article

References (45)

1. Howard VB 1987 Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628
2. Ginsenberg HN 1996 Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45(Suppl 3):S27-S30
3. American Diabetes Association 1989 Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 12:573-579
4. Reaven EP, Reaven GM 1974 Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats: effect of diet and duration of insulin deficiency. J Clin Invest 54:1167-1178
5. Chen Y-D I, Risser TR, Cully M, Reaven GM 1979 Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes 28:893-898
6. Rauramma R, Kuusela P, Hietanen E 1980 Adipose, muscle and lung tissue lipoprotein lipase activities in young streptozotocin treated rats. Horm Metab Res 12:591-595
7. Nakai T, Oida K, Tamai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R 1984 Lipoprotein lipases activities in heart muscle of streptozotocininduced diabetic rats. Horm Metab Res 16:67-70
8. Tavangar K, Murata Y, Pedersen ME, Goers JF, Hoffman AR, Kraemer FB 1992 Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest 90:1672-1678
9. O'Looney P, Irwin D, Briscoe P, Vahouny GV 1985 Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J Biol Chem 260:428-432
10. Jiao S, Matsuzawa Y, Matsubara K, Kihara S, Nakamura T, Tokunaga K, Kubo M, Tarui S 1988 Increased activity of intestinal acyl-CoA:cholesterol acyltransferase in rats with streptozotocin-induced diabetes and restoration by insulin supplementation. Diabetes 37:342-346
11. Maechler P, Wollheim CB, Bentzen CL, Niesor E 1992 Role of the intestinal acyl-CoA:cholesterol acyltransferase activity in the hyperresponse of diabetic rats to dietary cholesterol. J Lipid Res 33:1475-1484
12. Hori M, Satoh M, Furukawa K, Sakamoto Y, Hakamata H, Komohara Y, Tekeya M, Sasaki Y, Miyazaki A, Horiuchi S 2004 Acyl-coenzyme A: cholesterol acyltransferase-2 (ACAT-2) is responsible for elevated intestinalACAT activity in diabetic rats. Arterioscler Thromb Vasc Biol 24:1689-1695
13. Gleeson A, Anderson K, Owens D, Bennett A, Collins P, Jhonson A, White D, Tomkin GH 1999 The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42: 944-948
14. Bloks VW, Bakker-van Waarde WM, Verkade HJ, Kema IP, Wolters H, Vink E, Groen AK, Kuipers F 2004 Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 47:104-112
15. Preiss-Landl K, Zimmermann R, Hämmerle G, Zechner R 2002 Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13:471-481
16. Aktin E, Meng HC 1972 Release of clearing factor lipase (lipoprotein lipase) in vivo and from isolated perfused hearts of alloxan diabetic rats. Diabetes 21:149-156
17. Elkeles RS, Williams E 1974 Post-heparin lipolytic activity and tissue lipoprotein lipase activity in the alloxan-diabetic rat. Clin Sci Mol Med 46:661-664
18. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T 1992 Rabbit very low density lipoprotein receptor: a low density lipoprotein-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256
19. Yamamoto T, Takahashi S, Sakai J, Kawarabayasi Y 1993 The very low density lipoprotein receptor-A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc Med 3:144-148
20. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, Suzuki H, Kawarabayasi Y, Yamamoto T 1994 Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem 269:2173-2182
21. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T 1995 Enhancement of the binding of triglyceride-rich lipoprotein to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270:15747-15754
22. Niemeier A, Gåfvels ME, Heeren J, Meyer N, Angelin B, Beisiegel U 1996 VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J Lipid Res 37:1733-1742
23. Argraves KM, Battey FD, MacCalman CD, MacCrae KR, Gåfvels ME, Kozarsky KF, Chappell DA, Strauss III JF, Strickland DK 1995 The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem 270: 26550-26557
24. Battey FD, Gåfvels ME, FitzGerald DJ, Argraves WS, Chappell DA, Strauss III JF, Stricklund DK 1994 The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem 269:23268-23273
25. Argraves KM, Kozarsky KF, Fallon JT, Harpel PC, Strickland DK 1997 The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 100:2170-2181
26. Nakazato K, Ishibashi T, Shindo J, Shiomi M, Maruyama Y 1996 Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am J Pathol 149:1831-1838
27. Multhaupt HAB, Gåfvels ME, Kariko K, Jin H, Arenas-Ellit C, Goldman BI, Strauss III JF, Angelin B, Warhol MJ, McCare KR 1996 Expression of VLDL receptor in the vascular wall. Am J Pathol 148:1985-1997
28. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S 1998 Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97:1079-1086
29. Kosaka S, Takahashi S, Masamura K, Kanehara H, Sakai J, Tohda G, Okada E, Oida K, Iwasaki T, Hattori H, Kodama T, Yamamoto T, Miyamori I 2001 Evidence of macrophage foam cell formation by very low density lipoprotein receptor: interferon-γ inhibition of VLDL receptor expression and foam cell formation in macrophages. Circulation 103:1142-1147
30. Kamataki A, Takahashi S, Masamura K, Iwasaki T, Hattori H, Naiki H, Yamada K, Suzuki J, Miyamori I, Sakai J, Fujino T, Yamamoto TT 2002 Remnant lipoprotein particles are taken up into myocardium through VLDL receptor: a possible mechanism for cardiac fatty acid metabolism. Biochem Biophys Res Commun 293:1007-1013
31. Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT2004 The very low density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb 11:200-208
32. Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH 1994 Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 269:26411-26418
33. Vaziri ND, Liang K 1997 Down regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int 51:913-919
34. Liang K, Vaziri ND 1997 Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int 51:1761-1765
35. Sato T, Liang K, Vaziri ND 2002 Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Kidney Int 61:157-162
36. Bollag DM, Edelstein SJ 1991 Preparation for protein isolation. In: Bollag DM, Rozycki MD, Edelstein SJ, eds. Protein methods. New York: Wiley-Liss; 1-43
37. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
38. Okada K, Hirano T, Ran J, Adachi M 2004 Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens Res 27:293-299
39. Swami S, Sztalryd C, Kraemer FB 1996 Effects of streptozotocin-induced diabetes on low density lipoprotein receptor expression in rat adipose tissue. J Lipid Res 37:229-236
40. Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J 1995 Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA 92:8453-8457
41. Gourdriaan JR, Tacken PJ, Dahlmans VEH, Gijbels MJJ, van Dijk KW, Havekes LM, Jong MC 2001 Protection from obesity in mice lacking the VLDL receptor. Arteriscler Thromb Vasc Biol 21:1488-1493
42. Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, van Dijk KW, Hofker MH 2000 LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL transgenic and knockout mice. J Lipid Res 41:2055-2062
43. Gourdriaan JR, Santo SM, Voshol PJ, Teusink B, van Dijk KW, Van Viijman BJ, Romijin JA, Havekes LM, Rensen PC 2004 The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J Lipid Res 45:1475-1481
44. Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, and Goldberg IJ 2002 Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J Biol Chem 277:10037-10043
45. Sakthivel R, Zhang J-C, Strickland DK, Gåfvels M, McCrae KR 2001 Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation. J Biol Chem 276:555-562